| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 16.02▲ | 16.16▼ | 16.31▼ | 18.55▼ | 18.80▼ |
| MA10 | 16.02▲ | 16.26▼ | 17.29▼ | 18.64▼ | 18.54▼ |
| MA20 | 16.09▲ | 17.42▼ | 18.25▼ | 19.54▼ | 21.32▼ |
| MA50 | 16.29▼ | 18.31▼ | 18.47▼ | 19.08▼ | 28.60▼ |
| MA100 | 17.01▼ | 18.36▼ | 19.15▼ | 21.89▼ | 37.20▼ |
| MA200 | 18.17▼ | 19.30▼ | 19.27▼ | 26.25▼ | 29.95▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.015▲ | -0.088▼ | -0.336▼ | -0.227▼ | 0.277▲ |
| RSI | 50.036▲ | 31.701▼ | 31.028▼ | 35.743▼ | 33.847▼ |
| STOCH | 40.053 | 30.652 | 12.568▼ | 39.458 | 44.580 |
| WILL %R | -26.582 | -89.410▼ | -89.791▼ | -93.178▼ | -94.686▼ |
| CCI | 51.240 | -65.355 | -76.480 | -185.813▼ | -125.777▼ |
| RSI | $CAI RSI(14) Crossed Below 50 | Set Alert |
| MA | $CAI Price Crossed Below MA(50) | Set Alert |
| MA | $CAI Price Crossed Below MA(26) | Set Alert |
| MA | $CAI Price Crossed Below MA(13) | Set Alert |
| MA | $CAI Price Crossed Below MA(7) | Set Alert |
| ▼ GAP | $CAI Open Gap Down %5 | Set Alert |
| ▼ GAP | $CAI Open Gap Down %3 | Set Alert |
| ▼ GAP | $CAI Open Gap Down %2 | Set Alert |
| ▼ BREAK | $CAI Price Breaks 60 Days Low | Set Alert |
| ▼ BREAK | $CAI Price Breaks 30 Days Low | Set Alert |
| ▼ BREAK | $CAI Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $CAI Price Breaks 10 Days Low | Set Alert |
|
Friday, May 08, 2026 07:42 AM
Q1 2026 earnings call: 79% revenue growth, EBITDA/FCF positive, Detect MCED launch prep, guidance reaffirmed—read key insights.
|
|
Thursday, May 07, 2026 02:52 PM
Caris Life Sciences (NASDAQ:CAI) reported first-quarter 2026 results highlighted by sharp year-over-year revenue growth, improving margins, and continued progress across its pipeline, including a key ...
|
|
Monday, May 04, 2026 05:30 AM
Caris Life Sciences® (NASDAQ: CAI), a leading, patient‑centric, next‑generation AI TechBio company and precision medicine pioneer, today announced that Caris ChromoSeq™ has received MolDX approval, a ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/05/26 | 16.80 | 17.39 | 15.71 | 16.15 | 8,861,406 |
| 07/05/26 | 19.13 | 20.02 | 18.99 | 19.84 | 3,332,292 |
| 06/05/26 | 19.23 | 19.265 | 18.135 | 19.13 | 1,671,247 |
| 05/05/26 | 18.85 | 19.02 | 18.10 | 18.95 | 1,719,138 |
| 04/05/26 | 18.34 | 19.00 | 18.28 | 18.69 | 1,536,330 |
| 01/05/26 | 18.052 | 18.87 | 18.015 | 18.47 | 1,948,079 |
| 30/04/26 | 17.80 | 19.01 | 17.755 | 19.00 | 1,635,492 |
| 29/04/26 | 18.24 | 18.26 | 17.395 | 17.77 | 2,298,278 |
| 28/04/26 | 19.85 | 19.85 | 18.39 | 18.44 | 1,794,799 |
| 27/04/26 | 20.16 | 20.73 | 19.91 | 19.93 | 1,286,030 |
|
|
||||
|
|
||||
|
|